This week’s spotlight contributor, Rutgers Cancer Institute of New Jersey, is highlighting cancer genomics, breast cancer research, pancreatic cancer research, and the New York Giants.
All articles by Rutgers are available here.
Spotlight: Shridar Ganesan’s work on cancer genomics and breast cancer
- Physician-Scientist Shridar Ganesan, MD, PhD: Bridging the Lab and Clinic
By Rutgers Cancer Institute of New Jersey | Nov. 10, 2022
Dr. Shridar Ganesan came to Rutgers Cancer Institute of New Jersey in 2005. His medical training began at Yale University, from where he graduated with both an MD and a PhD in cell biology. He then completed a medical residency at the Brigham and Women’s Hospital in Boston and served as a Chief Medical Resident. This was followed by a fellowship in medical oncology at the Dana-Farber Cancer Institute.
As a physician/scientist, Dr. Ganesan runs a basic science laboratory focused on cancer genomics and breast cancer biology and sees patients in the Stacy Goldstein Breast Cancer Center at Rutgers Cancer Institute. In the clinic, he works collaboratively with experts across multi-disciplines and has the opportunity to put theory into practice as we aim to develop the next generation of targeted treatments for breast cancer.
With a research interest in breast cancer biology and DNA repair, Dr. Ganesan is currently exploring how DNA repair defects in cancers can be exploited to develop novel effective treatments. He is also active in applying next-generation sequencing technology to identify specific genomic changes in cancers that can be therapeutically targeted.
Tiki Barber photo archive
- Former New York Giant Tiki Barber Visits Pediatric Cancer Patients
By Rutgers Cancer Institute of New Jersey | Nov. 9, 2022
In November of 2006, Tiki Barber, former NFL running back for the New York Giants, visited pediatric cancer patients at Rutgers Cancer Institute of New Jersey. Tiki Barber has been an advocate for cancer since his mother’s breast cancer diagnosis in August of 1996. As a public figure, he gets to tell her story and advocate for cancer patients across New Jersey.
Video: The state of pancreatic cancer research in 2013, 2015
- Spotlight on Pancreatic Cancer Research: 2013
By Rutgers Cancer Institute of New Jersey | Nov. 9, 2022
In the May 2013 installment of “Spotlight on Middlesex County,” Middlesex County Commissioner Director Ronald G. Rios talks about research taking place at Rutgers Cancer Institute of New Jersey regarding pancreatic cancer. Rutgers Cancer Institute researcher and associate director for education and training Dr. Edmund Lattime and Les Jones, director of the Middlesex County Office of Health Services, join the conversation.
- Spotlight on Pancreatic Cancer Research: 2015
By Rutgers Cancer Institute of New Jersey | Nov. 9, 2022
U.S. Congressman Frank Pallone, Jr. and researcher Dr. Edmund Lattime of Rutgers Cancer Institute of New Jersey talk with Middlesex County Commissioner Director Ronald G. Rios about research taking place at the Institute to explore new treatments for pancreatic cancer in the April 2015 installment of “Spotlight on Middlesex County.”
This column features the latest posts to the Cancer History Project by our growing list of contributors.
The Cancer History Project is a free, web-based, collaborative resource intended to mark the 50th anniversary of the National Cancer Act and designed to continue in perpetuity. The objective is to assemble a robust collection of historical documents and make them freely available.
Access to the Cancer History Project is open to the public at CancerHistoryProject.com. You can also follow us on Twitter at @CancerHistProj, or follow our podcast.
Is your institution a contributor to the Cancer History Project? Eligible institutions include cancer centers, advocacy groups, professional societies, pharmaceutical companies, and key organizations in oncology.
To apply to become a contributor, please contact admin@cancerhistoryproject.com.
